Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 313

1.

Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions.

Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W; APOL1 Stakeholders Project.

Am J Nephrol. 2019 Sep 3:1-9. doi: 10.1159/000502675. [Epub ahead of print]

PMID:
31480040
2.

APOL1 Kidney Risk Variants and Cardiovascular Disease: An Individual Participant Data Meta-Analysis.

Grams ME, Surapaneni A, Ballew SH, Appel LJ, Boerwinkle E, Boulware LE, Chen TK, Coresh J, Cushman M, Divers J, Gutiérrez OM, Irvin MR, Ix JH, Kopp JB, Kuller LH, Langefeld CD, Lipkowitz MS, Mukamal KJ, Musani SK, Naik RP, Pajewski NM, Peralta CA, Tin A, Wassel CL, Wilson JG, Winkler CA, Young BA, Zakai NA, Freedman BI.

J Am Soc Nephrol. 2019 Aug 5. pii: ASN.2019030240. doi: 10.1681/ASN.2019030240. [Epub ahead of print]

PMID:
31383730
3.

Chronic kidney disease in propionic acidemia.

Shchelochkov OA, Manoli I, Sloan JL, Ferry S, Pass A, Van Ryzin C, Myles J, Schoenfeld M, McGuire P, Rosing DR, Levin MD, Kopp JB, Venditti CP.

Genet Med. 2019 Jun 28. doi: 10.1038/s41436-019-0593-z. [Epub ahead of print]

PMID:
31249402
4.

Optimal management of HIV- positive adults at risk for kidney disease in Nigeria (Renal Risk Reduction "R3" Trial): protocol and study design.

Aliyu MH, Wudil UJ, Ingles DJ, Shepherd BE, Gong W, Musa BM, Muhammad H, Sani MU, Abdu A, Nalado AM, Atanda A, Ahonkhai AA, Ikizler TA, Winkler CA, Kopp JB, Kimmel PL, Wester CW.

Trials. 2019 Jun 10;20(1):341. doi: 10.1186/s13063-019-3436-y.

5.

Renal Failure Patients in Disasters.

Lempert KD, Kopp JB.

Disaster Med Public Health Prep. 2019 May 6:1-9. doi: 10.1017/dmp.2018.142. [Epub ahead of print]

PMID:
31057134
6.

Gut microbiome-derived phenyl sulfate contributes to albuminuria in diabetic kidney disease.

Kikuchi K, Saigusa D, Kanemitsu Y, Matsumoto Y, Thanai P, Suzuki N, Mise K, Yamaguchi H, Nakamura T, Asaji K, Mukawa C, Tsukamoto H, Sato T, Oikawa Y, Iwasaki T, Oe Y, Tsukimi T, Fukuda NN, Ho HJ, Nanto-Hara F, Ogura J, Saito R, Nagao S, Ohsaki Y, Shimada S, Suzuki T, Toyohara T, Mishima E, Shima H, Akiyama Y, Akiyama Y, Ichijo M, Matsuhashi T, Matsuo A, Ogata Y, Yang CC, Suzuki C, Breeggemann MC, Heymann J, Shimizu M, Ogawa S, Takahashi N, Suzuki T, Owada Y, Kure S, Mano N, Soga T, Wada T, Kopp JB, Fukuda S, Hozawa A, Yamamoto M, Ito S, Wada J, Tomioka Y, Abe T.

Nat Commun. 2019 Apr 23;10(1):1835. doi: 10.1038/s41467-019-09735-4.

7.

APOL1 renal risk variants promote cholesterol accumulation in tissues and cultured macrophages from APOL1 transgenic mice.

Ryu JH, Ge M, Merscher S, Rosenberg AZ, Desante M, Roshanravan H, Okamoto K, Shin MK, Hoek M, Fornoni A, Kopp JB.

PLoS One. 2019 Apr 18;14(4):e0211559. doi: 10.1371/journal.pone.0211559. eCollection 2019.

8.

Survival Advantage of African American Dialysis Patients with End-Stage Renal Disease Causes Related to APOL1.

Lertdumrongluk P, Streja E, Rhee CM, Moradi H, Chang Y, Reddy U, Tantisattamo E, Kalantar-Zadeh K, Kopp JB.

Cardiorenal Med. 2019;9(4):212-221. doi: 10.1159/000496472. Epub 2019 Apr 17.

PMID:
30995638
9.

Open-Label Clinical Trials of Oral Pulse Dexamethasone for Adults with Idiopathic Nephrotic Syndrome.

Cho ME, Branton MH, Smith DA, Bartlett L, Howard L, Reynolds JC, Rosenstein D, Sethi S, Nava MB, Barisoni L, Fervenza FC, Kopp JB.

Am J Nephrol. 2019;49(5):377-385. doi: 10.1159/000497064. Epub 2019 Apr 9.

PMID:
30965344
10.

c-Src is in the effector pathway linking uPAR and podocyte injury.

Kopp JB, Heymann J.

J Clin Invest. 2019 Apr 2;129(5):1827-1829. doi: 10.1172/JCI127927. eCollection 2019 Apr 2.

11.

Impact of APOL1 Genetic Variants on HIV-1 Infection and Disease Progression.

An P, Kirk GD, Limou S, Binns-Roemer E, Kopp JB, Winkler CA.

Front Immunol. 2019 Jan 24;10:53. doi: 10.3389/fimmu.2019.00053. eCollection 2019.

12.

One Actor, Many Roles: Histopathologies Associated With APOL1 Genetic Variants.

Kopp JB, Rosenberg AZ.

Adv Anat Pathol. 2019 May;26(3):215-219. doi: 10.1097/PAP.0000000000000221. Review.

PMID:
30624253
13.

Expanding the spectrum of APOL1-related renal disease: de novo collapsing glomerulopathy following kidney transplant.

Kopp JB.

Kidney Int. 2018 Dec;94(6):1048-1050. doi: 10.1016/j.kint.2018.09.006.

PMID:
30466562
14.

NPHS2 V260E Is a Frequent Cause of Steroid-Resistant Nephrotic Syndrome in Black South African Children.

Asharam K, Bhimma R, David VA, Coovadia HM, Qulu WP, Naicker T, Gillies CE, Vega-Warner V, Johnson RC, Limou S, Kopp JB, Sampson M, Nelson GW, Winkler CA.

Kidney Int Rep. 2018 Jul 29;3(6):1354-1362. doi: 10.1016/j.ekir.2018.07.017. eCollection 2018 Nov.

15.

APOL1 risk allele RNA contributes to renal toxicity by activating protein kinase R.

Okamoto K, Rausch JW, Wakashin H, Fu Y, Chung JY, Dummer PD, Shin MK, Chandra P, Suzuki K, Shrivastav S, Rosenberg AZ, Hewitt SM, Ray PE, Noiri E, Le Grice SFJ, Hoek M, Han Z, Winkler CA, Kopp JB.

Commun Biol. 2018 Nov 7;1:188. doi: 10.1038/s42003-018-0188-2. eCollection 2018.

16.

APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.

Freedman BI, Limou S, Ma L, Kopp JB.

Am J Kidney Dis. 2018 Nov;72(5 Suppl 1):S8-S16. doi: 10.1053/j.ajkd.2018.06.020. Review.

PMID:
30343724
17.

APOL1-miR-193 Axis as a Bifunctional Regulator of the Glomerular Parietal Epithelium: Maintaining Parietal Cell Phenotype versus Promoting Podocyte Differentiation.

Jessee J, Kopp JB.

Am J Pathol. 2018 Nov;188(11):2461-2463. doi: 10.1016/j.ajpath.2018.08.002. Epub 2018 Sep 8.

PMID:
30201493
18.

Fetal-Not Maternal-APOL1 Genotype Associated with Risk for Preeclampsia in Those with African Ancestry.

Reidy KJ, Hjorten RC, Simpson CL, Rosenberg AZ, Rosenblum SD, Kovesdy CP, Tylavsky FA, Myrie J, Ruiz BL, Haque S, Mozhui K, Nelson GW, David VA, Yang X, Suzuki M, Jacob J, Reznik SE, Kaskel FJ, Kopp JB, Winkler CA, Davis RL.

Am J Hum Genet. 2018 Sep 6;103(3):367-376. doi: 10.1016/j.ajhg.2018.08.002. Epub 2018 Aug 30.

19.

Genetics, Genomics, and Precision Medicine in End-Stage Kidney Disease.

Kopp JB, Winkler CA.

Semin Nephrol. 2018 Jul;38(4):317-324. doi: 10.1016/j.semnephrol.2018.05.002. Review.

PMID:
30082052
20.

Association of APOL1 With Heart Failure With Preserved Ejection Fraction in Postmenopausal African American Women.

Franceschini N, Kopp JB, Barac A, Martin LW, Li Y, Qian H, Reiner AP, Pollak M, Wallace RB, Rosamond WD, Winkler CA.

JAMA Cardiol. 2018 Aug 1;3(8):712-720. doi: 10.1001/jamacardio.2018.1827.

21.

APOL1 Nephropathy Risk Variants and Incident Cardiovascular Disease Events in Community-Dwelling Black Adults.

Gutiérrez OM, Irvin MR, Chaudhary NS, Cushman M, Zakai NA, David VA, Limou S, Pamir N, Reiner AP, Naik RP, Sale MM, Safford MM, Hyacinth HI, Judd SE, Kopp JB, Winkler CA.

Circ Genom Precis Med. 2018 Jun;11(6):e002098. doi: 10.1161/CIRCGEN.117.002098.

22.

Association of Sickle Cell Trait With Ischemic Stroke Among African Americans: A Meta-analysis.

Hyacinth HI, Carty CL, Seals SR, Irvin MR, Naik RP, Burke GL, Zakai NA, Wilson JG, Franceschini N, Winkler CA, David VA, Kopp JB, Judd SE, Adams RJ, Longstreth WT Jr, Egede L, Lackland DT, Taylor H, Manson JE, Howard V, Allison M, Gee BE, Correa A, Safford MM, Arnett DK, Howard G, Reiner AP, Cushman M.

JAMA Neurol. 2018 Jul 1;75(7):802-807. doi: 10.1001/jamaneurol.2018.0571.

23.

Kidney Diseases Associated with Human Immunodeficiency Virus Infection.

Cohen SD, Kopp JB, Kimmel PL.

N Engl J Med. 2018 Apr 26;378(17):1655-6. doi: 10.1056/NEJMc1800396. No abstract available.

PMID:
29694807
24.

Global glomerulosclerosis in primary nephrotic syndrome: including age as a variable to predict renal outcomes.

Kopp JB.

Kidney Int. 2018 May;93(5):1043-1044. doi: 10.1016/j.kint.2018.01.020.

PMID:
29680021
25.

Genetic Testing in Clinical Settings.

Franceschini N, Frick A, Kopp JB.

Am J Kidney Dis. 2018 Oct;72(4):569-581. doi: 10.1053/j.ajkd.2018.02.351. Epub 2018 Apr 11. Review.

PMID:
29655499
26.

Apolipoprotein L1 nephropathies: 2017 in review.

Kopp JB, Roshanravan H, Okamoto K.

Curr Opin Nephrol Hypertens. 2018 May;27(3):153-158. doi: 10.1097/MNH.0000000000000399. Review.

PMID:
29389775
27.

ApoL1 renal risk variants induce aberrant THP-1 monocyte differentiation and increase eicosanoid production via enhanced expression of cyclooxygenase-2.

Lee H, Roshanravan H, Wang Y, Okamoto K, Ryu J, Shrivastav S, Qu P, Kopp JB.

Am J Physiol Renal Physiol. 2018 Jul 1;315(1):F140-F150. doi: 10.1152/ajprenal.00254.2017. Epub 2018 Jan 10.

28.

Randomized Clinical Trial Design to Assess Abatacept in Resistant Nephrotic Syndrome.

Trachtman H, Gipson DS, Somers M, Spino C, Adler S, Holzman L, Kopp JB, Sedor J, Overfield S, Elegbe A, Maldonado M, Greka A.

Kidney Int Rep. 2017 Aug 31;3(1):115-121. doi: 10.1016/j.ekir.2017.08.013. eCollection 2018 Jan.

29.

APOL1 Risk Variants Independently Associated With Early Cardiovascular Disease Death.

Hughson MD, Hoy WE, Mott SA, Bertram JF, Winkler CA, Kopp JB.

Kidney Int Rep. 2017 Aug 24;3(1):89-98. doi: 10.1016/j.ekir.2017.08.007. eCollection 2018 Jan.

30.

APOL1 Genotype and Renal Function of Black Living Donors.

Doshi MD, Ortigosa-Goggins M, Garg AX, Li L, Poggio ED, Winkler CA, Kopp JB.

J Am Soc Nephrol. 2018 Apr;29(4):1309-1316. doi: 10.1681/ASN.2017060658. Epub 2018 Jan 16.

31.

Kidney Diseases Associated with Human Immunodeficiency Virus Infection.

Cohen SD, Kopp JB, Kimmel PL.

N Engl J Med. 2017 Dec 14;377(24):2363-2374. doi: 10.1056/NEJMra1508467. Review. No abstract available. Erratum in: N Engl J Med. 2018 Apr 26; 378(17):1657.

PMID:
29236630
32.

Opposing Roles of Dendritic Cell Subsets in Experimental GN.

Brähler S, Zinselmeyer BH, Raju S, Nitschke M, Suleiman H, Saunders BT, Johnson MW, Böhner AMC, Viehmann SF, Theisen DJ, Kretzer NM, Briseño CG, Zaitsev K, Ornatsky O, Chang Q, Carrero JA, Kopp JB, Artyomov MN, Kurts C, Murphy KM, Miner JH, Shaw AS.

J Am Soc Nephrol. 2018 Jan;29(1):138-154. doi: 10.1681/ASN.2017030270. Epub 2017 Dec 7.

33.

Whole Exome Sequencing of Patients with Steroid-Resistant Nephrotic Syndrome.

Warejko JK, Tan W, Daga A, Schapiro D, Lawson JA, Shril S, Lovric S, Ashraf S, Rao J, Hermle T, Jobst-Schwan T, Widmeier E, Majmundar AJ, Schneider R, Gee HY, Schmidt JM, Vivante A, van der Ven AT, Ityel H, Chen J, Sadowski CE, Kohl S, Pabst WL, Nakayama M, Somers MJG, Rodig NM, Daouk G, Baum M, Stein DR, Ferguson MA, Traum AZ, Soliman NA, Kari JA, El Desoky S, Fathy H, Zenker M, Bakkaloglu SA, Müller D, Noyan A, Ozaltin F, Cadnapaphornchai MA, Hashmi S, Hopcian J, Kopp JB, Benador N, Bockenhauer D, Bogdanovic R, Stajić N, Chernin G, Ettenger R, Fehrenbach H, Kemper M, Munarriz RL, Podracka L, Büscher R, Serdaroglu E, Tasic V, Mane S, Lifton RP, Braun DA, Hildebrandt F.

Clin J Am Soc Nephrol. 2018 Jan 6;13(1):53-62. doi: 10.2215/CJN.04120417. Epub 2017 Nov 10.

34.

APOL1 Renal Risk Variants: Fertile Soil for HIV-Associated Nephropathy.

Kopp JB, Heymann J, Winkler CA.

Semin Nephrol. 2017 Nov;37(6):514-519. doi: 10.1016/j.semnephrol.2017.07.004. Review.

35.

FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.

Wang XX, Wang D, Luo Y, Myakala K, Dobrinskikh E, Rosenberg AZ, Levi J, Kopp JB, Field A, Hill A, Lucia S, Qiu L, Jiang T, Peng Y, Orlicky D, Garcia G, Herman-Edelstein M, D'Agati V, Henriksen K, Adorini L, Pruzanski M, Xie C, Krausz KW, Gonzalez FJ, Ranjit S, Dvornikov A, Gratton E, Levi M.

J Am Soc Nephrol. 2018 Jan;29(1):118-137. doi: 10.1681/ASN.2017020222. Epub 2017 Oct 31.

36.

HIV-1 viral protein R (Vpr) induces fatty liver in mice via LXRα and PPARα dysregulation: implications for HIV-specific pathogenesis of NAFLD.

Agarwal N, Iyer D, Gabbi C, Saha P, Patel SG, Mo Q, Chang B, Goswami B, Schubert U, Kopp JB, Lewis DE, Balasubramanyam A.

Sci Rep. 2017 Oct 17;7(1):13362. doi: 10.1038/s41598-017-13835-w.

37.

APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults.

Gutiérrez OM, Limou S, Lin F, Peralta CA, Kramer HJ, Carr JJ, Bibbins-Domingo K, Winkler CA, Lewis CE, Kopp JB.

Kidney Int. 2018 Mar;93(3):727-732. doi: 10.1016/j.kint.2017.08.019. Epub 2017 Oct 14.

38.

A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease.

Hayek SS, Koh KH, Grams ME, Wei C, Ko YA, Li J, Samelko B, Lee H, Dande RR, Lee HW, Hahm E, Peev V, Tracy M, Tardi NJ, Gupta V, Altintas MM, Garborcauskas G, Stojanovic N, Winkler CA, Lipkowitz MS, Tin A, Inker LA, Levey AS, Zeier M, Freedman BI, Kopp JB, Skorecki K, Coresh J, Quyyumi AA, Sever S, Reiser J.

Nat Med. 2017 Aug;23(8):945-953. doi: 10.1038/nm.4362. Epub 2017 Jun 26.

39.

Gingival recession in mandibular incisors and symphysis morphology-a retrospective cohort study.

Mazurova K, Kopp JB, Renkema AM, Pandis N, Katsaros C, Fudalej PS.

Eur J Orthod. 2018 Apr 6;40(2):185-192. doi: 10.1093/ejo/cjx046.

PMID:
28637273
40.

Chronic Kidney Disease in the Aging Human Immunodeficiency Virus-Infected Population.

Kopp JB.

J Infect Dis. 2017 Sep 15;216(6):619-621. doi: 10.1093/infdis/jix205. No abstract available. Erratum in: J Infect Dis. 2017 Sep 15;216(6):786.

41.

APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults.

Chen TK, Estrella MM, Vittinghoff E, Lin F, Gutierrez OM, Kramer H, Lewis CE, Kopp JB, Allen NB, Winkler CA, Bibbins-Domingo KB, Peralta CA.

Kidney Int. 2017 Oct;92(4):964-971. doi: 10.1016/j.kint.2017.03.028. Epub 2017 May 23.

42.

Effect of Antiretroviral Therapy on Bone and Renal Health in Young Adults Infected With HIV in Early Life.

Unsal AB, Mattingly AS, Jones SE, Purdy JB, Reynolds JC, Kopp JB, Hazra R, Hadigan CM.

J Clin Endocrinol Metab. 2017 Aug 1;102(8):2896-2904. doi: 10.1210/jc.2017-00197.

43.

Therapeutics for APOL1 nephropathies: putting out the fire in the podocyte.

Heymann J, Winkler CA, Hoek M, Susztak K, Kopp JB.

Nephrol Dial Transplant. 2017 Jan 1;32(suppl_1):i65-i70. doi: 10.1093/ndt/gfw402. Review.

44.

Absence of APOL1 risk alleles in a remote living Australian Aboriginal group with high rates of CKD, hypertension, diabetes, and cardiovascular disease.

Hoy WE, Kopp JB, Mott SA, Winkler CA.

Kidney Int. 2017 Apr;91(4):990. doi: 10.1016/j.kint.2016.11.031. No abstract available.

45.

Sickle Cell Trait and the Risk of ESRD in Blacks.

Naik RP, Irvin MR, Judd S, Gutiérrez OM, Zakai NA, Derebail VK, Peralta C, Lewis MR, Zhi D, Arnett D, McClellan W, Wilson JG, Reiner AP, Kopp JB, Winkler CA, Cushman M.

J Am Soc Nephrol. 2017 Jul;28(7):2180-2187. doi: 10.1681/ASN.2016101086. Epub 2017 Mar 9.

46.

Focal Segmental Glomerulosclerosis.

Rosenberg AZ, Kopp JB.

Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-517. doi: 10.2215/CJN.05960616. Epub 2017 Feb 27. Review. Erratum in: Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1889.

47.

Transgenic expression of human APOL1 risk variants in podocytes induces kidney disease in mice.

Beckerman P, Bi-Karchin J, Park AS, Qiu C, Dummer PD, Soomro I, Boustany-Kari CM, Pullen SS, Miner JH, Hu CA, Rohacs T, Inoue K, Ishibe S, Saleem MA, Palmer MB, Cuervo AM, Kopp JB, Susztak K.

Nat Med. 2017 Apr;23(4):429-438. doi: 10.1038/nm.4287. Epub 2017 Feb 20.

48.

SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE.

Wang XX, Levi J, Luo Y, Myakala K, Herman-Edelstein M, Qiu L, Wang D, Peng Y, Grenz A, Lucia S, Dobrinskikh E, D'Agati VD, Koepsell H, Kopp JB, Rosenberg AZ, Levi M.

J Biol Chem. 2017 Mar 31;292(13):5335-5348. doi: 10.1074/jbc.M117.779520. Epub 2017 Feb 14.

49.

Extracellular microRNA signature in chronic kidney disease.

Muralidharan J, Ramezani A, Hubal M, Knoblach S, Shrivastav S, Karandish S, Scott R, Maxwell N, Ozturk S, Beddhu S, Kopp JB, Raj DS.

Am J Physiol Renal Physiol. 2017 Jun 1;312(6):F982-F991. doi: 10.1152/ajprenal.00569.2016. Epub 2017 Jan 11.

50.

Renal and Cardiovascular Morbidities Associated with APOL1 Status among African-American and Non-African-American Children with Focal Segmental Glomerulosclerosis.

Woroniecki RP, Ng DK, Limou S, Winkler CA, Reidy KJ, Mitsnefes M, Sampson MG, Wong CS, Warady BA, Furth SL, Kopp JB, Kaskel FJ.

Front Pediatr. 2016 Nov 17;4:122. eCollection 2016.

Supplemental Content

Support Center